Latest News

Acaster Lloyd Consulting are looking for participants to take part in a research study about caregivers’ and children’s Experiences of taking an oral peanut protein powder (immunotherapy) treatment or 2. Their thoughts…

Aimmune Therapeutics’ PALFORZIA® has been approved by the European Commission as a treatment for peanut allergy. The European Commission (EC) has approved PALFORZIA®  for the treatment of peanut allergy, making it the…

Allergy Therapeutics PLC – Sussex-based biotechnology firm focused on allergy vaccines – Initiates peanut allergy biomarker study with Imperial College London to confirm potential of novel peanut vaccine candidate. The study aims…

The Anaphylaxis Campaign, the only UK-wide charity operating solely for the growing numbers of people at risk from severe allergic reactions, has welcomed a new Ambassador to help raise awareness and create a…

Dr June Raine, Chief Executive of the Medicines and Healthcare products Regulatory Agency (MHRA), said: “We have this evening (Wednesday 9 December 2020) issued updated guidance to COVID-19 vaccination centres about the…

Derby Coroner’s Court has ended the inquest into the death of Muhammed Musa Akbar, (known as Musa) a 12-year-old boy who died on 15 January 2019 after suffering a suspected severe allergic…

The May Contain Break the Stigma campaign empowers young people to speak up about their allergies and feel confident addressing them throughout their lives. The campaign features inspiring allergy advocates from TV,…

In two unrelated incidents, two restaurant owners have received substantial court fines this month, following successful prosecutions after their customers suffered severe allergic reactions as a result of being served their allergens…

DBV Technologies, a biopharmaceutical company and Corporate Member of the Campaign, announced on November 5 that its product Viaskin™ Peanut (DBV712) has been validated by the European Medicines Agency (EMA). The validation…